Citi Downgrades Atara Biotherapeutics (ATRA) to Neutral

December 9, 2020 4:38 AM

Citi analyst Yigal Nochomovitz downgraded Atara Biotherapeutics (NASDAQ: ATRA) from Buy ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found